With a market cap of $356.2 billion, North Chicago, Illinois-based AbbVie Inc. (ABBV) operates in the pharmaceutical sector.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

which is why it's considered a Dividend King despite its seemingly short history. By spinning off, AbbVie has been able to ...

Option chain shows key data for AbbVie's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AbbVie.

AbbVie has a lower P/E than the aggregate P/E of 112.06 of the Biotechnology industry. Ideally, one might believe that the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AbbVie ABBV is set to report third-quarter earnings on Oct. 30, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $14.28 billion and $2.93 per share, ...

Below is a chart showing the trailing twelve month trading history for AbbVie Inc ... If an investor was to purchase shares of ABBV stock at the current price level of $193.76/share, and then ...

AbbVie (ABBV) closed the most recent trading ... that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank ...

During this period, the Zacks Large Cap Pharmaceuticals industry, which AbbVie falls in, has lost 3.6%. The key question now is: What could be the stock's future direction? While media releases or ...